Liver transplantation in HIV/hepatitis co-infection

Journal of HIV Therapy

Volumn 12, Issue 1, 2007, Pages 24-35

  Miró, José M ^a   Agüero, Fernando ^b   Laguno, Montserrat ^b   Tuset, Montserrat ^b   Cervera, Carlos ^b   Moreno, Asuncion ^b   Garcìa Valdecasas, Juan Carlos ^b   Rimola, Antonio ^b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INTERACTION; GRAFT REJECTION; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; RECURRENT DISEASE; REVIEW;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG INTERACTIONS; GRAFT REJECTION; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSION; LIVER TRANSPLANTATION; RECURRENCE;

EID: 39849096297     PISSN: 14620308     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Bica I, McGovern B, Dhar R et al. Increasing mortality due to endstage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis, 2001, 32, 492-497.
2. Miró JM, Laguno M, Moreno A, Rimola A and the Hospital Clinic OLT In HIV Working Group. Management of end stage liver disease (ESLD): What is the current role of orthotopic liver transplantation (OLT). J Hepatol, 2006, 44 (Suppl 1), S140-145.
3. Rubin RH, Tolkoff-Rubin NE. The problem of human immunodeficiency virus (HIV) infection and transplantation. Transplant Int, 1988, 1, 36-42.
4. Samuel D, Duclos Vallee JC, Teicher E, Vittecoq D. Liver transplantation in patients with HIV infection. J Hepatol, 2003, 39, 3-6.
5. Roland ME, Stock PG. Review of solid-organ transplantation in HIV-infected patients. Transplantation, 2003, 75, 425-429.
6. Fung J, Eghtesad B, Patel-Tom K et al. Liver transplantation in patients with HIV infection. Liver Transpl, 2004, 10 (Suppl 2), S39-S53.
7. Neff GW, Sherman KE, Eghtesad B, Fung J. Review article: current status of liver transplantation in HIV-infected patients. Aliment Pharmacol Ther, 2004, 20, 993-1000.
8. Miró JM, Montejo M, Rufi G et al. Liver transplantation in patients with HIV infection: a reality in 2004. Enferm Infecc Microbiol Clin, 2004, 22, 529-538.
9. Tzakis AG, Cooper MH, Dummer JS et al. Transplantation in HIV-positive patients. Transplantation, 1990, 49, 354-358.
10. Erice A, Rhame FS, Heussner RC et al. Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review. Rev Infect Dis, 1991, 13, 537-547.
11. Bouscarat F, Samuel D, Simon F et al. An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1. Clin Infect Dis, 1994, 19, 854-859.
12. Gordon FH, Mistry PK, Sabin CA, Lee CA. Outcome of orthotopic liver transplantation in patients with haemophilia. Gut, 1998, 42, 744-749.
13. Ragni MV, Belle SH, Im K et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis, 2003, 188, 1412-1420.
14. Schliefer K, PaarW, Aydermir G et al. Orthotopic liver transplantation in a 33-year-old patient with fulminate hepatitis B and HIV infection. Dtsch Med Wochnschr, 2000, 125, 523-526.
15. Norris S, Taylor C, Muiesan P et al. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl, 2004, 10, 1271-1278.
16. Prachalias AA, Pozniak A, Taylor C et al. Liver transplantation in adults coinfected with HIV. Transplantation, 2001, 72, 1684-1688.
17. Bouscarat F, Samuel D, Simon F et al. An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1. Clin Infect Dis, 1994, 19, 854-859.
18. Ronald M, Carlson L, Ragni M et al. Solid organ transplantation in HIV-infected recipients: 47 cases in the HAART era. XIV International AIDS Conference. Barcelona, Spain, 2002, Abstr. MoOrB1060
19. Moreno S, Fortun J, Quereda C et al. Liver transplantation in HIV-infected recipients. Liver Transpl, 2005, 11, 76-81.
20. Radecke K, Fruhauf NR,MillerMet al. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis. Liver Int, 2005, 25, 101-108.
21. Neff GW, Bonham A, Tzakis AG et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl, 2003, 9, 239-247.
22. Vogel M, Voigt E, Schafer N et al. Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients: outcome of 7 patients from the Bonn cohort. Liver Transpl, 2005, 11, 1515-1521.
23. Duclos-Vallee JC, Vittecoq D, Teicher E et al. Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients. J Hepatol, 2005, 42, 341-349.
24. Duclos-Vallee JC, Teicher E, Feray C et al. Liver transplantation of HIV-HCV and HIV-HBV coinfected patients: a large experience in a single centre. Abstract number 410. Liver Transplant, 2006, 12(Suppl 1), C-103.
25. Grossi P, Tumietto F, Costigliola P et al. Liver transplantation in HIV-infected individuals: results of the Italian national program. Transplantation, 2006, 82(Suppl 2), 446, Abstr. 1125
26. de Vera ME, Dvorchik I, Tom K et al. Survival of liver transplant patients co-infected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant, 2006, 6, 2983-2993.
27. Miró JM,MontejoM, Vargas V et al. Orthotopic liver Transplantation (OLT) in HIV-1-Infected Patients in Spain: a prospective cohort study of 50 cases (2002-2005). 13th Conference on Retroviruses and Opportunistic Infections, Denver, Colorado. 5-9 February 2006, Abstr. 875.
28. Hamers FF, Downs AM. The changing face of the HIV epidemic in western Europe: what are the implications for public health policies? Lancet, 2004, 364, 83-94.
29. Rockstroh J, Mocroft A, Soriano V et al. Influence of hepatitis C coinfection on HIV disease progression within the EuroSIDA cohort. 9th European AIDS Conference.Warsaw, Poland, 25-29 October 2003. Abstr. F12/4.
30. Konopnicki D, Mocroft A, de Wit S et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS, 2005, 19, 593-601.
31. Gonzalez-Garcìa JJ, Mahillo B, Hernandez S et al. Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study. Enferm Infecc Microbiol Clin, 2005, 23, 340-348.
32. O'Grady J, Taylor C, Brook G. Guidelines for liver transplantation in patients with HIV infection (2005). HIV Med, 2005, 6(Suppl 2), 149-153.
33. Di Benedetto F, de Ruvo N, Berretta M et al. Don't deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era. J Clin Oncol, 2006, 24, e26-e27.
34. Miró JM, Torre-Cisneros J, Moreno A et al. GESIDA/GESITRASEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain - March, 2005. Enferm Infecc Microbiol Clin, 2005, 23, 353-362.
35. Hirsch MS, Brun-Vezinet F, Clotet B et al. Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. Clin Infect Dis, 2003, 37, 113-128.
36. Liu LU, Schiano TD, Lau N et al. Survival and risk of recidivism in methadone-dependent patients undergoing liver transplantation. Am J Transplant, 2003, 3, 1273-1277.
37. Anonymous. Solid organ transplantation in the HIV-infected patient. Am J Transplant, 2004, 4(Suppl 10), 83-88.
38. Roland M, Stock PG. Liver transplantation in HIV-Infected Recipients. Semin Liver Dis, 2006, 26, 273-284.
39. Miro JM, Murillas J, Laguno M et al. Natural history and prognosis of end stage liver disease (ESLD) in Spanish HIV-1 infected patients: a prospective cohort study of 104 patients (1999-2004). 10th European AIDS Conference. Dublin, Ireland, 17-20 November 2005. Abstr. PS7/1.
40. Pineda JA, Romero-Gomez M, Diaz-Garcia F et al. HIV co-infection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology, 2005, 41, 779-789.
41. Merchante N, Giron-Gonzalez JA, Gonzalez-Serrano M, et al. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS, 2006, 20, 49-57.
42. Maida I, NunezM, Gonzalez-Lahoz J, Soriano V. Liver transplantation in HIV-HCV coinfected candidates: what is the most appropriate time for evaluation? AIDS Res Hum Retroviruses, 2005, 21, 599-601.
43. Ragni MV, Eghtesad B, Schlesinger KW et al. Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl, 2005, 11, 1425-1430.
44. Cardenas A, Gines P. Management of complications of cirrhosis in patients awaiting liver transplantation. J Hepatol, 2005, 42(Suppl 1), S124-S133.
45. Llovet JM, Fuster J, Bruix J. Barcelona Clinic Liver Cancer Group. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl, 2004, 10(2 Suppl 1), S115-S120.
46. Hammer SM, Saag MS, Schechter M et al. Treatment for adult HIV infection. 2006 Recommendations of the International AIDS Society-USA Panel. J Am Med Assoc, 2006, 296, 827-843.
47. The EACS Guidelines Group. European Guidelines for Clinical Management end treatment of HIV-infected adults in Europe. AIDS, 2003, 17(Suppl 2), S3-S26.
48. Expert Committee of GESIDA and the National AIDS Plan. Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (Update January 2007). Enferm Infecc Microbiol Clin, 2007, 25, 32-53.
49. Wyles DL, Gerber J. Antiretroviral drug pharmacokinetics in hepatitis with hepatic dysfunction. Clin Infect Dis, 2005, 40, 174-181.
50. Back D, Gibbons S. The University of Liverpool HIV drug interactions website: . asp?pharmacology/pharma-main.asp [with access: 18/02/2007].
51. Tuset M, Miró JM, Codina C, Ribas J, Ed. Guía de interacciones en HIV: http://www.interaccionesHIV.com [with access: 18/02/2007].
52. Roland ME, Bernard L, Braff J, Stock PG. Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patients. Arch InternMed, 2003, 163, 1773-1778.
53. Margolis, D, Kewn S, Coull JJ et al. The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNA. J Acquir Immune Defic Syndr, 2002, 31, 45-49.
54. Stock PG, Roland ME, Carlson L et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation, 2003, 76, 370-375.
55. Roland ME. Solid-organ transplantation in HIV-infected patients in the potent antiretroviral therapy era. Top HIV Med, 2004, 12, 73-76.
56. Jain AK, Venkataramanan R, Shapiro R et al. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl, 2002, 8, 841-845.
57. Paterson DL, Singh N. Interactions between tacrolimus and antimicrobial agents. Clin Infect Dis, 1997, 25, 1430-1440.
58. Izzedine H, Launay-Vacher V, Baumelou A, Deray G. Antiretroviral and immunosuppressive drug-drug interactions: an update. Kidney Int, 2004, 66, 532-541.
59. Brinkman K, Huysmans F, Burger DM. Pharmacokinetic interaction between saquinavir and cyclosporine. Ann Intern Med, 1998, 129, 914-915.
60. Jain AK, Venkataramanan R, Fridell JA et al. Nelfinavir, a protease inhibitor, increases sirolimus levels in liver transplantation patient: a case report. Liver Transpl, 2002, 8, 838-840.
61. Vogel M, Voigt E, Michaelis HC et al. Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients. Liver Transpl, 2004, 10, 939-944.
62. Tseng A, Nguyen ME, Cardella C, Humar A, Conly J. Probable interaction between efavirenz and cyclosporine. AIDS, 2002, 16, 505-506.
63. Frassetto L, Baluom M, Jacobsen W et al. Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients. Transplantation, 2005, 80, 13-17.
64. Teicher E, Taburet AM, Vincent I et al. Management of drug-to-drug interactions between Tacrolimus and HAART. 12th Conference on Retroviruses and Opportunistic Infections. Boston, MA, 22-25 February 2005. Abstr. 662.
65. Schonder KS, Schullo MA, Okusanya O. Tacrolimus and lopinavir/ritonavir interaction in liver transplantation. Ann Pharmacother, 2003, 37, 1793-1796.
66. Schvarcz R, Rudbeck G, Soderdahl G, Stahle L. Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV). Transplantation, 2000, 69, 2194-2195.
67. Sheikh AM, Wolf DC, Lebovics E et al. Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels. Transplantation, 1999, 68, 307-309.
68. Teicher E, Vittecoq D, Taburet AM et al. Liver transplantation in HIV co-infected patients treated by enfuvirtide. 13th Conference on Retroviruses and Opportunistic Infections. Denver, CO, USA. 5- 8 February 2006. Abstr. 874.
69. Soriano V, Miró JM, García-Samaniego J et al. Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations. J Viral Hepatol, 2004, 11, 2-17.
70. Soriano V, Sulkowski M, Bergin C et al. Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel. AIDS, 2002, 16, 813-828.
71. Duclos Vallée J, Feray C, Sebagh M et al. Survival and prognostic factors in a large cohort of HIV-HCV coinfected patients transplanted in a single centre. 57th Annual Meeting of the American Association for the Study of Liver Diseases. Boston, MA, USA, 27-31 October 2006, Abstr. 772.
72. Vennarecci G, Mutimer D, Ettorre G et al. Liver transplantation in HIV-positive patients. Abstract number 457. Liver Transplant, 2006, 12 (Suppl 1), C-115.
73. Castells L, Esteban JI, Bilbao I et al. Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients. Antivir Ther, 2006, 11, 1061-1070. (Pubitemid 44955182)
74. Castells L, Escartin A, Bilbao I et al. Liver transplantation in HIV-HCV coinfected patients: a case-control study. Transplantation, 2007, 83, 354-358.
75. Miró JM, Montejo M, Castells LL et al. Treatment of Spanish HIV-infected patients with recurrent hepatitis C virus (HCV) after liver transplantation (OLT) with pegylated interferon (PEG-INF) plus ribavirin (RBV): preliminary results of the FIPSE OLT-HIV-05 - GESIDA 45-05 Cohort Study (2002-2006). 14th Conference on Retroviruses and Opportunistic Infections. Los Angeles, California, USA. 25-28 February 2007, Abstr. 890.
76. Soriano V, Puoti M, Bonacini M et al. Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIVHBV International Panel. AIDS, 2005, 19, 221-240.
77. Terrault NA, Carter JT, Carlson L et al. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transpl, 2006, 12, 801-807.